A European, non-interventional, multicentre, registry-based post-authorisation safety study to evaluate the long-term safety of Loargys treatment in arginase 1 deficiency patients in standard clinical careFirst published 07/07/2025 Last updated 07/07/2025 EU PAS number: EUPAS1000000555StudyPlanned